Promising brain cancer vaccine made available to patients with no other options
NCT ID NCT04802447
First seen Sep 30, 2025 · Last updated May 20, 2026 · Updated 33 times
Summary
This program gives certain glioblastoma patients at Roswell Park access to SurVaxM, a treatment that may help slow tumor growth and extend survival. It is for patients who have no other treatment options or who have already benefited from SurVaxM in a prior study. The goal is to provide continued care while monitoring safety and effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.